• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受儿茶酚胺输注的危重症患者对胺碘酮的血流动力学反应。

Hemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusions.

作者信息

Holt A W

机构信息

Department of Anaesthesia and Intensive Care, Flinders Medical Centre, Adelaide, Australia.

出版信息

Crit Care Med. 1989 Dec;17(12):1270-6. doi: 10.1097/00003246-198912000-00006.

DOI:10.1097/00003246-198912000-00006
PMID:2591222
Abstract

The hemodynamic response after an iv loading dose of amiodarone for resistant supraventricular tachyarrhythmias was studied in ten critically ill patients receiving a catecholamine infusion for shock. A loading dose of amiodarone, 3.7 to 5.0 mg/kg, was infused over 2 h while the catecholamine infusion dose requirements were monitored. There was a significant decrease in heart rate (mean 16%, p less than .01), and an increase in stroke volume index (mean 29%, p less than .01) and left ventricular stroke work index (mean 34%, p less than .01). Cardiac index, oxygen availability index, and mean arterial pressure were not changed significantly. The reported adrenoreceptor antagonism of amiodarone did not change catecholamine dose requirements in this study. In nine of ten patients, sinus rhythm was achieved and maintained. The loading dose of amiodarone had no significant acute effect on plasma digoxin concentrations. Despite good arrhythmia control, mortality was high.

摘要

在十名因休克而接受儿茶酚胺输注的重症患者中,研究了静脉注射负荷剂量胺碘酮治疗顽固性室上性快速心律失常后的血流动力学反应。负荷剂量的胺碘酮,3.7至5.0mg/kg,在2小时内输注,同时监测儿茶酚胺输注剂量需求。心率显著降低(平均16%,p<0.01),每搏量指数增加(平均29%,p<0.01),左心室每搏功指数增加(平均34%,p<0.01)。心脏指数、氧供指数和平均动脉压无显著变化。本研究中,胺碘酮报道的肾上腺素能受体拮抗作用未改变儿茶酚胺剂量需求。十名患者中有九名实现并维持了窦性心律。胺碘酮的负荷剂量对血浆地高辛浓度无显著急性影响。尽管心律失常控制良好,但死亡率很高。

相似文献

1
Hemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusions.接受儿茶酚胺输注的危重症患者对胺碘酮的血流动力学反应。
Crit Care Med. 1989 Dec;17(12):1270-6. doi: 10.1097/00003246-198912000-00006.
2
High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study.
Wien Klin Wochenschr. 2004 May 31;116(9-10):310-7. doi: 10.1007/BF03040901.
3
Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.静脉注射胺碘酮治疗对小儿心脏手术患者的急性血流动力学影响。
Clin Res Cardiol. 2008 Nov;97(11):801-10. doi: 10.1007/s00392-008-0683-4. Epub 2008 Jun 5.
4
Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study.1C 类抗心律失常药物(普罗帕酮)与胺碘酮治疗感染性休克时的室上性心律失常的疗效和安全性比较:一项前瞻性随机双盲研究方案。
BMJ Open. 2019 Sep 3;9(9):e031678. doi: 10.1136/bmjopen-2019-031678.
5
Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia.胺碘酮在复发性持续性室性心动过速患者急性和慢性治疗期间的血流动力学效应。
Clin Investig. 1992 May;70(5):416-20. doi: 10.1007/BF00235524.
6
Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone.
Pharmacol Res. 2017 Aug;122:118-126. doi: 10.1016/j.phrs.2017.06.004. Epub 2017 Jun 10.
7
Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.抗心律失常药物在急性心肌梗死中的血流动力学效应。
G Ital Cardiol. 1984 Oct;14(10):762-7.
8
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.静脉注射胺碘酮单独或与地高辛联合用于治疗新生儿和小婴儿危及生命的室上性快速心律失常。
Pediatr Emerg Care. 2010 Feb;26(2):82-4. doi: 10.1097/PEC.0b013e3181ce2f6a.
9
Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.静脉注射胺碘酮用于危重心房快速性心律失常患者的急性心率控制。
Am J Cardiol. 1998 Mar 1;81(5):594-8. doi: 10.1016/s0002-9149(97)00962-4.
10
Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.静脉注射胺碘酮对左心室功能减退及复发性室性心动过速患者的血流动力学影响。
Am Heart J. 1983 Oct;106(4 Pt 2):848-56. doi: 10.1016/0002-8703(83)90007-8.

引用本文的文献

1
Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill.胺碘酮的使用变化与危重症患者心房颤动复发风险增加有关。
Crit Care. 2016 Apr 2;20:90. doi: 10.1186/s13054-016-1252-2.
2
Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.静脉注射胺碘酮治疗对小儿心脏手术患者的急性血流动力学影响。
Clin Res Cardiol. 2008 Nov;97(11):801-10. doi: 10.1007/s00392-008-0683-4. Epub 2008 Jun 5.
3
Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework.
临床综述:医学重症监护患者新发房颤的治疗——一个临床框架
Crit Care. 2007;11(6):233. doi: 10.1186/cc6136.
4
Acute amiodarone-induced lung toxicity.急性胺碘酮所致肺毒性。
Intensive Care Med. 1998 Jun;24(6):626-30. doi: 10.1007/s001340050627.
5
Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone.
Intensive Care Med. 1993;19(1):48-52. doi: 10.1007/BF01709278.
6
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.胺碘酮。其药理特性概述及其在心律失常治疗中的应用综述。
Drugs. 1992 Jan;43(1):69-110. doi: 10.2165/00003495-199243010-00007.